A milk-based self-assemble rotavirus VP6-ferritin nanoparticle vaccine elicited protection against the viral infection

scholarly article by Zhipeng Li et al published 22 January 2019 in Journal of Nanobiotechnology

A milk-based self-assemble rotavirus VP6-ferritin nanoparticle vaccine elicited protection against the viral infection is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1111593650
P356DOI10.1186/S12951-019-0446-6
P932PMC publication ID6341625
P698PubMed publication ID30670042

P2093author name stringHong Wang
Zhipeng Li
Fengchao Wang
Deshun Shi
Qingyou Liu
Zhaojun Duan
Kuiqing Cui
Kongwei Huang
Fuhang Liu
P2860cites workNorovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis.Q52726208
Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses.Q53815580
Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus GastroenteritisQ56995254
Hematoxylin and Eosin Staining of Tissue and Cell SectionsQ58006521
Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activityQ70998772
The internal rotavirus protein VP6 primes for an enhanced neutralizing antibody responseQ73992558
Recombinant rotavirus inner core proteins produced in the milk of transgenic rabbits confer a high level of protection after intrarectal deliveryQ80607738
Production of two vaccinating recombinant rotavirus proteins in the milk of transgenic rabbitsQ81546580
Oral immunization with pBsVP6-transgenic alfalfa protects mice against rotavirus infectionQ81917238
Rotavirus vaccines WHO position paper: January 2013 - RecommendationsQ86916352
Characterization of bioactive recombinant human lysozyme expressed in milk of cloned transgenic cattleQ21004096
Rotaviruses: from pathogenesis to vaccinationQ24609374
A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacyQ26820819
Cattle mammary bioreactor generated by a novel procedure of transgenic cloning for large-scale production of functional human lactoferrinQ28473868
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodiesQ30430925
Oral Administration of a Seed-based Bivalent Rotavirus Vaccine Containing VP6 and NSP4 Induces Specific Immune Responses in MiceQ33740676
Sequence analysis of the gene (6) encoding the major capsid protein (VP6) of group C rotavirus: higher than expected homology to the corresponding protein from group A virusQ33945090
Recombinant protein expression in milk of livestock speciesQ34097145
Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis: analysis of clinical trials of human rotavirus vaccine.Q34290838
Human breast milk: A review on its composition and bioactivityQ34494389
Nutritional and physiologic significance of human milk proteinsQ34648576
Production of pharmaceutical proteins by transgenic animalsQ34744705
Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb.Q34791255
Expression and characterization of bioactive recombinant human alpha-lactalbumin in the milk of transgenic cloned cows.Q34889966
Secretory antibodies in breast milk promote long-term intestinal homeostasis by regulating the gut microbiota and host gene expressionQ35103038
More than one reason to rethink the use of peptides in vaccine designQ36808693
Ferritins: a family of molecules for iron storage, antioxidation and more.Q37301997
Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitisQ38028997
Modern subunit vaccines: development, components, and research opportunitiesQ38073752
Infant formula and infant nutrition: bioactive proteins of human milk and implications for composition of infant formulasQ38180950
Rotavirus VP6 preparations as a non-replicating vaccine candidates.Q38506308
Ferritin nanocages: A biological platform for drug delivery, imaging and theranostics in cancerQ38770216
Vaccine technologies: From whole organisms to rationally designed protein assembliesQ38806558
Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion.Q39290987
Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulinsQ39752998
Structure-based design of ferritin nanoparticle immunogens displaying antigenic loops of Neisseria gonorrhoeaeQ40104608
Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infantsQ40433532
Neutralizing antiviral B cell responsesQ41464284
Expression of rotavirus capsid protein VP6 in transgenic potato and its oral immunogenicity in miceQ44965400
Large scale production of recombinant human lactoferrin in the milk of transgenic cowsQ45231378
A plant-based multicomponent vaccine protects mice from enteric diseasesQ45877640
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectnanoparticleQ61231
pharmaceutical scienceQ7180763
bioengineeringQ580689
self-assemblyQ910150
molecular medicineQ3523816
rotavirus VP6Q123050125
P304page(s)13
P577publication date2019-01-22
P1433published inJournal of NanobiotechnologyQ15752156
P1476titleA milk-based self-assemble rotavirus VP6-ferritin nanoparticle vaccine elicited protection against the viral infection
P478volume17

Reverse relations

Q97092977A ferritin nanoparticle vaccine for foot-and-mouth disease virus elicited partial protection in micecites workP2860

Search more.